Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation ; volume:4 ; number:1 ; day:31 ; month:8 ; year:2012 ; pages:1-7 ; date:12.2012
Clinical epigenetics ; 4, Heft 1 (31.8.2012), 1-7, 12.2012
- Creator
-
Bennemann, Karla
- Contributor
-
Galm, Oliver
Wilop, Stefan
Schubert, Claudia
Brümmendorf, Tim Henrik
Jost, Edgar
SpringerLink (Online service)
- DOI
-
10.1186/1868-7083-4-12
- URN
-
urn:nbn:de:1111-2016072634024
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bennemann, Karla
- Galm, Oliver
- Wilop, Stefan
- Schubert, Claudia
- Brümmendorf, Tim Henrik
- Jost, Edgar
- SpringerLink (Online service)
Other Objects (12)
Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Targeted therapies for myeloproliferative neoplasms
Esophageal lesions in myeloproliferative neoplasms
Novel therapeutics in myeloproliferative neoplasms
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
New mouse models of myeloproliferative neoplasms
Myeloproliferative neoplasms : critical concepts and management
SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
Myeloproliferative neoplasms: cause, mechanism and treatment
Molecular pathogenesis of the myeloproliferative neoplasms
Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Targeted therapies for myeloproliferative neoplasms
Esophageal lesions in myeloproliferative neoplasms
Novel therapeutics in myeloproliferative neoplasms
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
New mouse models of myeloproliferative neoplasms
Myeloproliferative neoplasms : critical concepts and management
SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
Myeloproliferative neoplasms: cause, mechanism and treatment
Molecular pathogenesis of the myeloproliferative neoplasms
Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Targeted therapies for myeloproliferative neoplasms
Esophageal lesions in myeloproliferative neoplasms
Novel therapeutics in myeloproliferative neoplasms
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
New mouse models of myeloproliferative neoplasms
Myeloproliferative neoplasms : critical concepts and management
SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
Myeloproliferative neoplasms: cause, mechanism and treatment